RxDoctor Payments Data

Sundararaj Cherala, MD

Interventional Pain Medicine · Decatur, ILNPI 1689698359

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 62 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Nevro Corp. at 30.9% of the total. Reporting peaked in 2019 at $459 and has fallen 96.6% since, to $16 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in IL, where the typical reported total is $2,254.

$1,269in general payments, 2019–2025

Across 62 payments — averaging $20.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$392
  • AbbVie$200
  • Collegium Pharmaceutical, Inc.$140
  • Electronic Waveform Lab, Inc.$77
  • Pacira Therapeutics, Inc.$58
  • Tersera Therapeutics LLC$51
  • plus $351 from 15 others

What the payments were for

  • Food & beverage$1,269100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,269 in reported general payments places this provider in the 40th percentile of 93 interventional pain medicine providers in Illinois.

See all interventional pain medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$11,663
Medicare patients
28
Services billed
233

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen108$3,481
Fentanyl25$2,641
Diclofenac Sodium140$1,973
Gabapentin157$1,597
Tramadol Hcl212$1,362
Meloxicam381$1,292
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen34$1,062
Morphine Sulfate ErMorphine Sulfate21$899
Oxycodone Hcl66$712
Pregabalin32$594
Butalbital-Aspirin-CaffeineButalbital/Aspirin/Caffeine11$497
Tizanidine Hcl46$478
Hydromorphone Hcl20$311
Celecoxib20$291
Naproxen16$252

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Decatur

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →